VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,536 | -33.6% | 354,368 | -25.7% | 0.04% | -28.0% |
| Q2 2023 | $14,365 | -4.7% | 477,095 | +2.3% | 0.05% | -19.4% |
| Q1 2023 | $15,081 | +9.5% | 466,185 | -3.0% | 0.06% | +14.8% |
| Q4 2022 | $13,772 | -99.9% | 480,545 | +25.6% | 0.05% | +35.0% |
| Q3 2022 | $9,228,000 | -16.1% | 382,570 | +0.5% | 0.04% | -20.0% |
| Q2 2022 | $10,995,000 | -40.2% | 380,848 | -20.6% | 0.05% | -36.7% |
| Q1 2022 | $18,386,000 | +45.1% | 479,433 | +21.2% | 0.08% | +61.2% |
| Q4 2021 | $12,671,000 | -9.5% | 395,600 | -16.7% | 0.05% | -18.3% |
| Q3 2021 | $13,998,000 | -12.5% | 474,998 | +0.9% | 0.06% | -15.5% |
| Q2 2021 | $15,998,000 | +18.7% | 470,801 | +13.5% | 0.07% | +9.2% |
| Q1 2021 | $13,479,000 | -7.1% | 414,724 | +2.9% | 0.06% | -7.1% |
| Q4 2020 | $14,513,000 | -13.2% | 402,913 | -5.7% | 0.07% | -26.3% |
| Q3 2020 | $16,728,000 | -2.7% | 427,176 | -8.9% | 0.10% | -12.8% |
| Q2 2020 | $17,197,000 | +95.1% | 468,840 | +22.6% | 0.11% | +55.7% |
| Q1 2020 | $8,814,000 | +32.0% | 382,552 | +67.8% | 0.07% | +59.1% |
| Q4 2019 | $6,676,000 | -25.3% | 228,013 | -31.8% | 0.04% | -32.3% |
| Q3 2019 | $8,933,000 | +59.8% | 334,432 | +52.9% | 0.06% | +51.2% |
| Q2 2019 | $5,589,000 | +10.1% | 218,677 | -3.4% | 0.04% | +2.4% |
| Q1 2019 | $5,076,000 | +181.8% | 226,424 | +165.2% | 0.04% | +147.1% |
| Q4 2018 | $1,801,000 | +169.6% | 85,392 | +136.6% | 0.02% | +183.3% |
| Q3 2018 | $668,000 | +33.9% | 36,085 | +61.3% | 0.01% | +20.0% |
| Q2 2018 | $499,000 | -22.0% | 22,368 | -23.2% | 0.01% | -16.7% |
| Q1 2018 | $640,000 | -23.2% | 29,111 | -18.8% | 0.01% | -33.3% |
| Q4 2017 | $833,000 | -52.5% | 35,847 | -53.1% | 0.01% | -55.0% |
| Q3 2017 | $1,754,000 | +16.4% | 76,412 | +12.0% | 0.02% | +5.3% |
| Q2 2017 | $1,507,000 | +5.8% | 68,231 | +9.3% | 0.02% | 0.0% |
| Q1 2017 | $1,424,000 | -32.5% | 62,439 | -38.1% | 0.02% | -40.6% |
| Q4 2016 | $2,109,000 | +10.2% | 100,823 | +39.3% | 0.03% | -5.9% |
| Q3 2016 | $1,913,000 | – | 72,398 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |